Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Robbins

Showing results (101-110 of 223) with videos related to

Pageof 23
Sort By:
Clinical and Diagnostic Laboratory Immunology|August 31, 2001
Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussisB Trollfors, T Lagergård, J Taranger, et al.
Infection and Immunity|December 1, 1994
Synthesis and some immunologic properties of an O-acetyl pectin [poly(1-->4)-alpha-D-GalpA]-protein conjugate as a vaccine for typhoid feverS C Szu, S Bystricky, M Hinojosa-Ahumada, et al.
Annals of Internal Medicine|November 1, 1970
Pneumocystis carinii pneumonitisM Bradshaw, R L Myerowitz, R Schneerson, et al.
Infection and Immunity|May 11, 1975
Heteroimmunization to the capsular polysaccharide of Haemophilus influenzae type b induced by enteric cross-reacting bacteriaZ T Handzel, M Argaman, J C Parke, et al.
Vaccine|April 1, 1996
Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunizationK P Klugman, H J Koornhof, J B Robbins, et al.
Annals of the New York Academy of Sciences|May 31, 1995
Prevention of systemic infections caused by group B streptococcus and Staphylococcus aureus by multivalent polysaccharide-protein conjugate vaccinesJ B Robbins, R Schneerson, W F Vann, et al.
Infection and Immunity|December 1, 1979
Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharidesJ B Robbins, C J Lee, S C Rastogi, et al.
The Pediatric Infectious Disease Journal|March 1, 1990
Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemiaS Sarnaik, J Kaplan, G Schiffman, et al.
Infection and Immunity|November 1, 1994
Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccinesE Konadu, J B Robbins, J Shiloach, et al.
Developments in Biological Standardization|January 1, 1991
Immunologic evaluation of a pertussis toxoid vaccineJ B Robbins, B Trollfors, J Taranger, et al.
Pageof 23

Showing results (101-110 of 223) with videos related to

Sort By:
Pageof 23
Clinical and Diagnostic Laboratory Immunology|August 31, 2001
Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussisB Trollfors, T Lagergård, J Taranger, et al.
Infection and Immunity|December 1, 1994
Synthesis and some immunologic properties of an O-acetyl pectin [poly(1-->4)-alpha-D-GalpA]-protein conjugate as a vaccine for typhoid feverS C Szu, S Bystricky, M Hinojosa-Ahumada, et al.
Annals of Internal Medicine|November 1, 1970
Pneumocystis carinii pneumonitisM Bradshaw, R L Myerowitz, R Schneerson, et al.
Infection and Immunity|May 11, 1975
Heteroimmunization to the capsular polysaccharide of Haemophilus influenzae type b induced by enteric cross-reacting bacteriaZ T Handzel, M Argaman, J C Parke, et al.
Vaccine|April 1, 1996
Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunizationK P Klugman, H J Koornhof, J B Robbins, et al.
Annals of the New York Academy of Sciences|May 31, 1995
Prevention of systemic infections caused by group B streptococcus and Staphylococcus aureus by multivalent polysaccharide-protein conjugate vaccinesJ B Robbins, R Schneerson, W F Vann, et al.
Infection and Immunity|December 1, 1979
Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharidesJ B Robbins, C J Lee, S C Rastogi, et al.
The Pediatric Infectious Disease Journal|March 1, 1990
Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemiaS Sarnaik, J Kaplan, G Schiffman, et al.
Infection and Immunity|November 1, 1994
Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccinesE Konadu, J B Robbins, J Shiloach, et al.
Developments in Biological Standardization|January 1, 1991
Immunologic evaluation of a pertussis toxoid vaccineJ B Robbins, B Trollfors, J Taranger, et al.
Pageof 23